Literature DB >> 8698500

Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1.

Y P Shi1, U Sayed, S H Qari, J M Roberts, V Udhayakumar, A J Oloo, W A Hawley, D C Kaslow, B L Nahlen, A A Lal.   

Abstract

We have characterized the natural immune responses to the 19-kDa domain of merozoite surface protein 1 in individuals from an area of western Kenya in which malaria is holoendemic. We used the three known natural variant forms of the yeast-expressed recombinant 19-kDa fragment that are referred to as the E-KNG, Q-KNG, and E-TSR antigens. T-cell proliferative responses in individuals older than 15 years and the profile of immunoglobulin G (IgG) antibody isotypes in individuals from 2 to 74 years old were determined. Positive proliferative responses to the Q-KNG antigen were observed for 54% of the individuals, and 37 and 35% of the individuals responded to the E-KNG and E-TSR constructs, respectively. Considerable heterogeneity in the T-cell proliferative responses to these three variant antigens was observed in different individuals, suggesting that the 19-kDa antigen may contain variant-specific T epitopes. Among responses of the different isotypes of the IgG antibody, IgG1 and IgG3 isotype responses were predominant, and the prevalence and levels of the responses increased with age. We also found that a higher level of IgG1 antibody response correlated with lower parasite density among young age groups, suggesting that IgG1 antibody response may play a role in protection against malaria. However, there was no correlation between the IgG3 antibody level and protection. Furthermore, we observed that although the natural antibodies cross-reacted with all three variant 19-kDa antigens, IgG3 antibodies in 12 plasma samples recognized only the E-KNG and Q-KNG constructs and not the E-TSR antigen. This result suggests that the fine specificity of IgG3 antibodies differentiates among variant-specific natural B-cell determinants in the second epidermal growth factor domain (KNG and TSR) of the antigen.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698500      PMCID: PMC174131          DOI: 10.1128/iai.64.7.2716-2723.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth.

Authors:  S P Chang; H L Gibson; C T Lee-Ng; P J Barr; G S Hui
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

2.  Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum.

Authors:  K Tanabe; M Mackay; M Goman; J G Scaife
Journal:  J Mol Biol       Date:  1987-05-20       Impact factor: 5.469

3.  Topography of epitopes on a polymorphic schizont antigen of Plasmodium falciparum determined by the binding of monoclonal antibodies in a two-site radioimmunoassay.

Authors:  C F Wilson; R Anand; J T Clark; J S McBride
Journal:  Parasite Immunol       Date:  1987-11       Impact factor: 2.280

4.  Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1).

Authors:  L H Miller; T Roberts; M Shahabuddin; T F McCutchan
Journal:  Mol Biochem Parasitol       Date:  1993-05       Impact factor: 1.759

5.  Characterization of malaria transmission by Anopheles (Diptera: Culicidae) in western Kenya in preparation for malaria vaccine trials.

Authors:  J C Beier; P V Perkins; F K Onyango; T P Gargan; C N Oster; R E Whitmire; D K Koech; C R Roberts
Journal:  J Med Entomol       Date:  1990-07       Impact factor: 2.278

6.  Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP1(19)) variants secreted from Saccharomyces cerevisiae.

Authors:  D C Kaslow; G Hui; S Kumar
Journal:  Mol Biochem Parasitol       Date:  1994-02       Impact factor: 1.759

7.  Human immune response to MSP-1.

Authors:  A A Holder; E M Riley
Journal:  Parasitol Today       Date:  1996-05

8.  Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains.

Authors:  M J Blackman; I T Ling; S C Nicholls; A A Holder
Journal:  Mol Biochem Parasitol       Date:  1991-11       Impact factor: 1.759

9.  Epitopes in the 19kDa fragment of the Plasmodium falciparum major merozoite surface protein-1 (PfMSP-1(19)) recognized by human antibodies.

Authors:  S Shai; M J Blackman; A A Holder
Journal:  Parasite Immunol       Date:  1995-05       Impact factor: 2.280

10.  A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission.

Authors:  E M Riley; S Morris-Jones; M J Blackman; B M Greenwood; A A Holder
Journal:  Parasite Immunol       Date:  1993-09       Impact factor: 2.280

View more
  55 in total

1.  Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum.

Authors:  D R Cavanagh; C Dobaño; I M Elhassan; K Marsh; A Elhassan; L Hviid; E A Khalil; T G Theander; D E Arnot; J S McBride
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system.

Authors:  Alan L Y Pang; Caryn N Hashimoto; Leslie Q Tam; Z Q Meng; George S N Hui; Walter K K Ho
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

3.  Longitudinal studies of Plasmodium falciparum malaria in pregnant women living in a rural Cameroonian village with high perennial transmission.

Authors:  Rose F G Leke; Jude D Bioga; James Zhou; Genevieve G Fouda; Robert J I Leke; Viviane Tchinda; Rosette Megnekou; Josephine Fogako; Grace Sama; Philomina Gwanmesia; Germaine Bomback; Charles Nama; Ababacar Diouf; Naveen Bobbili; Diane Wallace Taylor
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

4.  Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant.

Authors:  C Yang; W E Collins; J S Sullivan; D C Kaslow; L Xiao; A A Lal
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

5.  Plasmodium falciparum- and merozoite surface protein 1-specific antibody isotype balance in immune Senegalese adults.

Authors:  C M Nguer; T O Diallo; A Diouf; A Tall; A Dieye; R Perraut; O Garraud
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

6.  Assessment of the humoral immune response against Plasmodium falciparum rhoptry-associated proteins 1 and 2.

Authors:  A Stowers; D Taylor; N Prescott; Q Cheng; J Cooper; A Saul
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

7.  Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria.

Authors:  I S Soares; G Levitus; J M Souza; H A Del Portillo; M M Rodrigues
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

8.  Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.

Authors:  Soe Soe; Michael Theisen; Christian Roussilhon; Khin-Saw Aye; Pierre Druilhe
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 9.  What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity.

Authors:  Samson M Kinyanjui; Philip Bejon; Faith H Osier; Peter C Bull; Kevin Marsh
Journal:  Malar J       Date:  2009-10-28       Impact factor: 2.979

10.  The Plasmodium falciparum merozoite surface protein-1 19 KD antibody response in the Peruvian Amazon predominantly targets the non-allele specific, shared sites of this antigen.

Authors:  Patrick L Sutton; Eva H Clark; Claudia Silva; OraLee H Branch
Journal:  Malar J       Date:  2010-01-04       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.